Minster Pharmaceuticals is Drug Discovery in United Kingdom that focus on negative symptoms business. Founded in 2005. They cover business area such as developer, pharmaceutical compound, neurological and psychiatric disorder, Tonabersat, Sabcomeline, segment, treatment, migraine, cognitive decline, negative symptom, schizophrenia.
2005
( 19 years old in 2024 )
Negative Symptoms
-
Audley End Business Centre
The Old Forge 56
Essex CB11 4JL
England, United Kingdom
Private
developerpharmaceutical compoundneurological and psychiatric disorderTonabersatSabcomelinesegmenttreatmentmigrainecognitive declinenegative symptomschizophrenia
* We use standard office opening hours in near Minster Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Minster Pharmaceuticals is Drug Discovery business from United Kingdom that founded in 2005 (19 years old in 2024), Minster Pharmaceuticals business is focusing on Negative Symptoms.
Minster Pharmaceuticals headquarter office and corporate office address is located in Audley End Business Centre The Old Forge 56 Essex CB11 4JL England, United Kingdom.
Minster Pharmaceuticals was founded in United Kingdom.
In 2024, Minster Pharmaceuticals is currently focus on negative symptoms sector.
Above is snippet of Google Trends for "negative symptoms" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Minster Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
